Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm

Takahashi Mio; Sakai Kensuke; Iwasa Naomi; Wada Michiko; Hino Makiko; Kurahashi Takashi; Ueno Mari; Nakagawa Hiroyuki

首页> 外文期刊>The journal of obstetrics and gynaecology research >Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm

【24h】

Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm

机译：诊断宫颈癌2018年分期系统的验证：FIGO 2009阶段IB1宫颈癌的回顾性分析2cm下肿瘤

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim The International Federation of Gynecology and Obstetrics (FIGO) revised the cervical cancer staging system in 2018. This study aims to validate the revised staging system in patients with tumors <2 cm in size who were classified as FIGO 2009 stage IB1.

机译：目的国际妇产科联合会（FIGO）于2018年修订了宫颈癌分期系统。本研究旨在验证FIGO 2009 IB1期肿瘤小于2 cm患者的修订分期系统。

著录项

来源
《The journal of obstetrics and gynaecology research 》 |2021年第5期| 共7页
作者
Takahashi Mio; Sakai Kensuke; Iwasa Naomi; Wada Michiko; Hino Makiko; Kurahashi Takashi; Ueno Mari; Nakagawa Hiroyuki;
展开▼
作者单位

Natl Hosp Org Saitama Hosp Dept Obstet &

Gynecol 2-1 Suwa Wako Saitama 3510102 Japan;

Natl Hosp Org Saitama Hosp Dept Obstet &

Gynecol 2-1 Suwa Wako Saitama 3510102 Japan;

Natl Hosp Org Saitama Hosp Dept Obstet &

Gynecol 2-1 Suwa Wako Saitama 3510102 Japan;

Natl Hosp Org Saitama Hosp Dept Obstet &

Gynecol 2-1 Suwa Wako Saitama 3510102 Japan;

Natl Hosp Org Saitama Hosp Dept Obstet &

Gynecol 2-1 Suwa Wako Saitama 3510102 Japan;

Natl Hosp Org Saitama Hosp Dept Obstet &

Gynecol 2-1 Suwa Wako Saitama 3510102 Japan;

Natl Hosp Org Saitama Hosp Dept Pathol Saitama Japan;

Natl Hosp Org Saitama Hosp Dept Obstet &

Gynecol 2-1 Suwa Wako Saitama 3510102 Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇产科学 ;
关键词
cervical cancer; FIGO 2018 system; lymphovascular space invasion; microinvasive; staging;

机译：宫颈癌;Figo 2018系统;淋巴血管空间入侵;微内瓦;分期;

相似文献

外文文献
中文文献
专利

1. Prognostic Factors for Patients with FIGO Stage-IB Cervical Squamous Cell Carcinoma: Does the Tumor Size (≤4 cm or ＞4 cm) Really Matter ? [J] . Ying Xiong, Lizhi Liang, Xiaoping Peng, 癌症生物学与医学（英文版） . 2007 ,第002期
2. A preliminary cervical cancer screening cascade for eight provinces rural Chinese women: a descriptive analysis of cervical cancer screening cases in a 3-stage framework [J] . Shu-Xia Wang, Jiu-Ling Wu, Rui-Min Zheng, 中华医学杂志（英文版） . 2019 ,第015期
3. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2?negative Breast Cancer [J] . Ling Xu, Jiang‑Hong Li, Jing‑Ming Ye, 中华医学杂志（英文版） . 2017 ,第016期
4. A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer [J] . Jingming Ye, Yinhua Liu, Wenjun Wang, 中国癌症研究（英文版） . 2017 ,第004期
5. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease? [J] . Ayhan Ali, Aslan Koray, Bulut Ayca Nazli, European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal . 2019 ,第期

机译：是宫颈癌的修订2018 FIGO分期系统比2009年以前分期为IB疾病的女性更高的宫颈癌更高的癌症吗？
6. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single Institution Patient Cohort. Is There a Will Rogers Phenomenon? [J] . Thomas T. V. Vengaloor, Gandhi S., Nittala M. R., International Journal of Radiation Oncology, Biology, Physics . 2019 ,第1Suppla期

机译：宫颈癌中阶段迁移使用FIGO 2018分期系统：使用单一机构患者队列的回顾性存活分析。有没有狂欢者的现象？
7. Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101) [J] . Kunieda Futoshi, Kasamatsu Takahiro, Arimoto Takahide, Japanese journal of clinical oncology. . 2015 ,第1期

机译：改良的子宫全切除术对直径小于等于2 cm的FIGO IB1期子宫宫颈癌患者的非随机确证试验：日本临床肿瘤学小组研究（JCOG1101）
8. Risk Factors Analysis based on the Cervical Cancer Screening Program performed on 728,704 women in Beijing, 2009 [C] . Lixin Tao, Xia Li, Qi Gao, Second joint biostatistics symposium (2012) . 2012

机译：基于宫颈癌筛查计划的危险因素分析，2009年在北京对728,704名妇女进行了研究
9. Association of PIK3CA and PTEN Genetic Alterations with Cervical Cancer Mortality and Tumor Recurrence [D] . Odekunle, Florence Femi. 2018

机译：PIK3CA和PTEN遗传改变与宫颈癌死亡率和肿瘤复发的关联
10. Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage [O] . Vincent Balaya, Benedetta Guani, Laurent Magaud, 2020

机译：验证2018年宫颈癌的FIGO分类：在IB1阶段应考虑淋巴血管空间入侵
11. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single Institution Patient Cohort. Is There a Will Rogers Phenomenon? [O] . T. V. Vengaloor Thomas, S. Gandhi, M.R. Nittala, 2019

机译：宫颈癌中阶段迁移使用FIGO 2018分期系统：使用单一机构患者队列的回顾性存活分析。有没有狂欢者的现象？
12. The Implications of Cost-Effectiveness Analysis of Medical Technology. Background Paper No. 2: Case Studies of Medical Technologies. Case Study No. 7: Allocating Costs and Benefits in Disease Prevention Programs: An Application to Cervical Cancer Screening [R] . Luce, B. R. 1981

机译：医疗技术成本效益分析的启示。背景文件第2号：医疗技术案例研究。案例研究第7号：在疾病预防计划中分配成本和收益：在宫颈癌筛查中的应用

Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm

摘要

著录项

相似文献

相关主题

期刊订阅